Medicaid expansion under the Affordable Care Act (ACA) is associated with better outcomes for patients with hormone receptor (HR)-negative, human...

FRIDAY, Oct. 25, 2024 -- Expanding Medicaid is associated with an increase in receipt of guideline-concordant treatment among nonelderly women newly...

MONDAY, Oct. 21, 2024 -- Pembrolizumab plus chemotherapy improves disease-free survival (DFS) in patients with high-risk endometrial cancer after...

HER2-targeted therapies, originally developed for breast cancer, may also benefit patients with rare bile duct cancer and HER2-mutated breast...

Using a gene signature technique to customize chemotherapy for patients with early triple negative breast cancer may be a promising strategy to...

Around 40% of postmenopausal hormone-positive breast cancer cases may be linked to excess body fat, suggests Spanish research published online in...

A new study from the MD Anderson Cancer Center reveals that quitting smoking within six months of a cancer diagnosis can significantly improve...

Medicaid expansion linked to better cancer care and survival rates for patients with aggressive breast cancer.

Learn how a gene signature technique personalizes chemotherapy for early triple-negative breast cancer, improving disease-free survival rates

A new drug called WNTinib can delay the growth of tumours and improve survival in hepatoblastoma, a type of liver cancer that occurs in young...